|
Vaccine Detail
rLSDV-RPV |
Vaccine Information |
- Vaccine Name: rLSDV-RPV
- Target Pathogen: rinderpest virus
- Vaccine Ontology ID: VO_0004763
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- Vector:
- Preparation: Recombinant capripox-rinderpest vaccine (Ngichabe et al., 2002).
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Cattle Response
- Vaccination Protocol: A dose of 10^5.3 TCID50/ml of the recombinant vaccine, determined previously as an effective dose, was injected subcutaneously in the shoulder region of each animal (Ngichabe et al., 2002).
- Vaccine Immune Response Type: VO_0003057
- Challenge Protocol: Two years after vaccination, cattle were challenged with virulent RPV (Ngichabe et al., 2002).
- Efficacy: In the case of LSDV, all of 4 vaccinated cattle challenged with virulent LSDV at 2 years were completely protected from clinical disease while 2 of 5 vaccinated cattle were completely protected at 3 years. The recombinant vaccine showed no loss of potency when stored lyophylized at 4 degrees C for up to 1 year (Ngichabe et al., 2002).
|
References |
Ngichabe et al., 2002: Ngichabe CK, Wamwayi HM, Ndungu EK, Mirangi PK, Bostock CJ, Black DN, Barrett T. Long term immunity in African cattle vaccinated with a recombinant capripox-rinderpest virus vaccine. Epidemiology and infection. 2002; 128(2); 343-349. [PubMed: 12002554].
|
|